SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001832
Filing Date
2021-09-20
Accepted
2021-09-20 16:17:36
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adgi-20210630.htm   iXBRL 10-Q 2604563
2 EX-10.5 adgi-20210630ex10_5.htm EX-10.5 391615
3 EX-10.6 adgi-20210630ex10_6.htm EX-10.6 266892
4 EX-10.7 adgi-20210630ex10_7.htm EX-10.7 287637
5 EX-31.1 adgi-20210630ex31_1.htm EX-31.1 20632
6 EX-31.2 adgi-20210630ex31_2.htm EX-31.2 21390
7 EX-32.1 adgi-20210630ex32_1.htm EX-32.1 12513
8 EX-32.2 adgi-20210630ex32_2.htm EX-32.2 12507
  Complete submission text file 0000950170-21-001832.txt   8838294

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adgi-20210630_pre.xml EX-101.PRE 276287
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adgi-20210630.xsd EX-101.SCH 45810
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adgi-20210630_lab.xml EX-101.LAB 350100
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adgi-20210630_cal.xml EX-101.CAL 22479
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adgi-20210630_def.xml EX-101.DEF 155349
14 EXTRACTED XBRL INSTANCE DOCUMENT adgi-20210630_htm.xml XML 1281721
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 211263503
SIC: 2836 Biological Products, (No Diagnostic Substances)